Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study
PaperCitations, authors & open-access status
Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 15 citations, 2024 year and hybrid oa status.
15
Citations
2024
Year
hybrid
OA Status